Amino acids in neurobiology: Neuroprotective and neurotoxic aspects of amino acids involved in neurotransmission and neuromodulation - General introduction

Amino Acids

Volumn 23, Issue 1-3, 2002, Pages 1-7

  Kretschmer, B D ^a,b   Schmidt, W J ^a,b   Kostrzewa, R M ^a,b   Herrera Marschitz, M ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; AMYLOID BETA PROTEIN; ANTIPARKINSON AGENT; BUTYRIC ACID DERIVATIVE; CYCLOLEUCINE; GLUTAMIC ACID; KAINIC ACID RECEPTOR; LEVODOPA; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NUCLEIC ACID; PHOSPHOLIPASE C; PROTEIN; QUISQUALIC ACID; SKF 38392;

ACETYLATION; ALZHEIMER DISEASE; BRAIN FUNCTION; BRAIN NERVE CELL; CELL DEATH; CELL FUNCTION; CELL SUBPOPULATION; CONFERENCE PAPER; GENE SEQUENCE; GENETIC CODE; GENOME; GLIA CELL; HUMAN; HUNTINGTON CHOREA; IMMUNOREACTIVITY; METABOLISM; MOLECULAR BIOLOGY; NEUROBIOLOGY; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; RNA TRANSCRIPTION; RNA TRANSLATION; SCHIZOPHRENIA; STOP CODON;

AMINO ACIDS; HUMANS; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; RECEPTORS, AMINO ACID;

EID: 0036389379     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260200027     Document Type: Conference Paper

References (75)

1. Archer T, Palomo T, Fredriksson A (2002) Restorative effects of glutamate antagonists in experimental parkinsonism. Amino Acids 23: 71-85
2. Bergman H (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436-1438
3. Burnashev N, Villarroel A, Sakman B (1996) Dimensions and ion selectivity of recombinant AMPA and kainite receptor channels and their dependence on Q/R site residues. J Physiol (Lond) 496: 165-173
4. Bernard V, Somogyi P, Bolam JP (1997) Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neuroscience 15: 819-833
5. Bischoff S, Barhanin J, Bettler B, Muller C, Heinemann S (1997) Spatial distribution of kainate receptors subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J Comp Neurol 379: 541-562
6. Bridges R, Stanley MS, Anderson MW, Cotman CW, Chamberlin R (1991) Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 34: 717-725
7. Calabresi P, Mercuri NB, Bernardi G (1993) Electrophysiology of dopamine-denervated striatal neurons. Brain 116: 433-452
8. Calabresi P, Pisani A, Centonze D, Bernardi G (1997) Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci Biobehav Rev 21: 519-523
9. Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221-226
10. Chen Q, Veenman CL, Reiner A (1996) Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 73: 715-731
11. Chen Q, Veenman CL, Knopp K, Yan Z, Medina L, Song WJ, Surmeier DJ, Reiner A (1998) Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum. Neuroscience 83: 749-761
12. Chéramy A, L'Hirondel M, Godeheu G, Artaud F, Glowinski J (1998) Direct and indirect presynaptic control of dopamine release by excitatory amino acids. Amino Acids 14: 63-68
13. Chizh BA (2002) Novel approaches to targeting glutamate receptors for the treatment of chronic pain. Amino Acids 23: 169-176
14. Collins (2001) That is in the International Human Genome Sequencing Consortium (2001). The authors, led by Collins agreed on not having any author name in the reference
15. B recognition site of NMDA receptors and its antagonists. Amino Acids 14: 205-206
16. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacological Rev 51: 8-61
17. Engidawork E, Chen Y, Dell'Anna E, Goiny M, Lubec G, Andersson K, Herrera-Marschitz M (1997) Effects of perinatal asphyxia on systemic and intracerebral glycolysis metabolism and pH in the rat. Exp Neurol 145: 390-396
18. Ghasemzadeh MB, Sharma S, Surmeier DJJ, Eberwine JH, Chesselet M-F (1996) Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol Pharmacol 49: 852-859
19. Herrera-Marschitz M, You Z-B, Goiny M, Meana JJ, Silveira R, Godukhin OV, Chen Y, Espinoza S, pettersson E, Loidl CF, Lubec G, Andersson K, Nylander I, Terenius L, Ungerstedt (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem 66: 1726-1735
20. Herrera-Marschitz M, Goiny M, You Z-B, Meana JJ, Pettersson E, Rodriguez-Puertas R, Xu Z-Q, Terenius L, Hökfelt T, Ungerstedt U (1997) On the release of glutamate and aspartate levels in the basal ganglia of the rat: interactions with monoamines and neuropeptides. Neuroscience & Biobehavioral Reviews 21: 489-495
21. Herrera-Marschitz M, Goiny M, You Z-B, Meana JJ, Engidawork E, Chen Y, Rodriguez-Puertas R, Broberger C, Andersson K, Terenius L, Hökfelt T, Ungerstedt U (1998) Release of endogenous excitatory amino acids in the neostriatum of the rat under physiological and pharmacologically-induced conditions. Amino Acids 14: 197-203
22. Herrera-Marschitz M, Kohlhauser C, Gomez-Urquijo S, Ubink R, Goiny M, Hökfelt T (2000) Excitatory amino acids, monoamine, and nitric oxide synthase systems in organotypic cultures: biochemical and immunohistochemical analysis. Amino Acids 19: 33-43
23. Houamed KM, Kuijper JL, Gilbert TL, Haldeman BA, O'Hara PJ, Mulvihill ER, Almers W, Hagen FS (1991) Cloning, expression, and gene structure of a G-protein-coupled glutamate receptor from rat brain. Science 252: 1318-1321
24. Hornykiewicz O (2002) L-DOPA: from a biologically inactive amino acids to a successful therapeutic agent. Amino Acids 23: 65-70
25. International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921
26. Jäger W, Goiny M, Herrera-Marschitz M, Brundin L, Fransson A, Canlon B (2000) Noise-induced aspartate and glutamate efflux in the 3 guinea pig cochlea and hearing loss. Exp Brain Res 134: 426-434
27. Kerner JA, Standaert DG, Penney JB, Young AB, Landwehrmeyer GB (1997) Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Mol Brain Res 48: 259-269
28. Kochman A, Koka K, Metodiewa D (2002) Submolecular adventures of brain tyrosine: what are we searching for now? Amino Acids 23: 95-101
29. Kostrzewa RM (1998) Observations relative to the neurotoxicity and neurotoxic potential of amino acids. Amino Acids 14: 171-173
30. Kostrzewa RM, Kostrzewa JP, Brus R (2000) Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids 19: 183-199
31. Kostrzewa RM, Kostrzewa JP, Brus R (2002) Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Amino Acids 23: 57-63
32. Kwok KHH, Tse YC, Wong RNS, Yung KKL (1997) Cellular localization of GluR1, GluR2/3 and GluR4 glutamate receptor subunits in neurons of the rat neostriatum. Brain Res 778: 43-55
33. Landwehrmeyer GB, Standaert DG, Testa CM, Penney JBJ, Young AB (1995) NMD Areceptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci 15: 5297-5307
34. Laurie DJ, Seeburg PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors dependent on subunit composition. Eur J Pharmacol 268: 335-345
35. Lindefors N, Brené S, Herrera-Marschitz M, Persson M (1989) Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Exp Brain Res 77: 611-620
36. Martin LJ, Blackstone CD, Levey AI, Higanir RL, Price DL (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53: 327-358
37. Meltzer LT, Christoffersen CL, Serpa KA (1997) Modulation of dopamine neuronal activity by glutamate receptor subtypes. Neurosci Biobehav Rev 21: 511-518
38. Monyer H, Burnasev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540
39. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258: 597-603
40. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335: 252-266
41. Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721
42. Ossowska K, Lorenc-Koci E, Konieczny J, Wolfarth S (1998) The role of striatal glutamate receptors in models of Parkinson's disease. Amino Acids 14: 11-15
43. Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, Pilc A (2000) The role of glutamate receptors in antipsychotic drug action. Amino Acids 19: 87-94
44. Patneau DP, Mayer ML (1990) Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 10: 2385-2399
45. Petralia RS, Yokotani N, Wenthold RJ (1994) Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14: 667-696
46. Petralia RS, Wang YX, Niedzielski AS, Wenthold RJ (1996) The metabotropic glutamate receptors, MGluR2 and MGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71: 949-976
47. Pettersson E, Herrera-Marschitz M, Rodriguez-Puertas R, Xu Z-Q, You Z-B, Hughes J, Elde RP, Ungerstedt U, Hökfelt T (1996) Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via D1-subtype of receptor. Neuroscience 74: 51-66
48. Rodriguez-Puertas R, Herrera-Marschitz M, Koistinaho J, Hökfelt T (1999) Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats. Neuroscience 89: 781-797
49. Romano C, Sesma MA, McDonald CT, O'Marrey K, Van Den Pol AN, Olney JW (1995) Distribution of metabotropic glutamate receptor mgluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455-469
50. Rogawski MA (2000) Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents - toward an understanding of their favourable tolerability. Amino Acids 19: 133-149
51. Sato K, Kiyama H, Tohyama M (1993) The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 52: 515-539
52. Schmidt WJ (1998) Dopamine-glutamate interactions in the basal ganglia. Amino Acids 14: 5-10
53. Setler PE, Sarau HM, Zirkle CL, Sanders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50: 419-422
54. Snyder GL, Fisone G, Morino P, Gundersen V, Ottersen OP, Hökfelt T, Greengard P (1993) Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the striatum. Proc Natl Acad Sci USA 90: 11277-11281
55. Sonsalla PK, Albers DS, Zeevalk GD (1998) Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism. Amino Acids 14: 69-74
56. Standaert DG, Testa CM, Young AB, Penney JB (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343: 1-16
57. Starr MS (1998) Antagonists of glutamate in the treatment of Parkinson's disease: from laboratory to the clinic. Amino Acids 14: 41-42
58. Svensson TH, Mathé JM (2000) Atypical antipsychotic-like effect of AMPA receptor antagonists in the rat. Amino Acids 19: 221-226
59. Tanabe Y, Masu M, Ishii T (1992) A family of metabotropic glutamate receptors. Neuron 8: 169-179
60. Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL (1998) Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res 780: 210-217
61. Tanabe Y, Nomura A, Masu M, Shigemoto R, Mizuno N, Nakanishi SJ (1993) Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. Neuroscience 13: 1372-1378
62. Testa CM, Standaert DG, Young AB, Penney JBJ (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neuroscience 14: 3005-3018
63. Testa CM, Standaert DG, Landwehrmeyer GB, Penney JBJ, Young AB (1995) Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons. J Comp Neurol 354: 241-252
64. Testa CM, Friberg IK, Weis SW, Standaert DG (1998) Immunohistochemical localization of metabotropic glutamate receptors mGluRa and mGluR2/3 in the rat basal ganglia. J Comp Neurol 390: 5-19
65. Tzschentke TM, Schmidt WJ (2000) Blockade of behavioral sensitization by MK-801: fact or artifact? A review of preclinical data. Psychopharmacology 151: 142-151
66. Venter JC et al (2001) The Human genome. Science 291: 1304-1351
67. Verhagen Metman L, Del Dotto P, Blanchet PJ, van den Munckhof P, Chase TN (1998) Blockade of glutamatergic transmission as treatment of dyskinesias and motor fluctuations in Parkinson's disease. Amino Acids 14: 75-82
68. Walker LC, Bian F, Callahan MJ, Lipinski WJ, Durham RA, LeVine H (2002) Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids 23: 87-93
69. Watanabe I, Inoue Y, Sakimura K, Mishina M (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3: 1138-1140
70. Watkins JC, Evans RH (1981) Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol 21: 165-204
71. Wolfarth S, Konieczny J, Lorenc-Koci E, Ossowska K, Pilc A (2000) The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity. Amino Acids 19: 95-101
72. Wollmuth LP, Sakmann B (1998) Different mechanisms of Ca2+ transport in NMDA and Ca2+- permeable AMPA glutamate receptor channels. J Gen Physiol 112: 623-636
73. Wüllner U, Standaert DG, Testa CM, Landwehrmeyer GB, Catania MV, Penney JBJ, Young AB (1994a) Glutamate receptor expression in rat striatum: effect of deafferentation. Brain Res 647: 209-219
74. Wüllner U, Testa CM, Catania MV, Young AB, Penney JBJ (1994b) Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res 645: 98-102
75. Zigmond MJ, Castro SL, Keefe KA, Abercrombie ED, Sved AF (1998) Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum. Amino Acids 14: 57-62